Double-Blind, Randomized, Placebo-Controlled Trial of MLN1202 on C-Reactive Protein Levels in Patients With Risk Factors for Cardiovascular Disease
Clinical trial NCT00715169 · COMPLETED
Trial details
- NCT number
- NCT00715169
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2006-04-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.